Clinical Trials Logo

Clinical Trial Summary

The study probes the effects of combined exposures to diesel exhaust and allergens on lung function and on the immune system, specifically focusing on the ability of a particle depletion technique to attenuate effects we and others have seen previously. Individuals are exposed to either filtered air (FA), carefully controlled levels of diesel exhaust (DE) or particle-depleted diesel exhaust (PDDE) in our exposure chamber, after which the investigators will administer an inhaled allergen challenge. 48h later, a procedure called bronchoscopy is used to collect samples from the lungs. After 1 month, the entire procedure is to be repeated with one of the alternate exposures. This will be repeated 4 times (4 exposures; 2 filtered air, 1 diesel exhaust, 1 particle-depleted diesel exhaust)


Clinical Trial Description

1. Purpose/Objective:

The aim of this study is to investigate the ability of depletion of diesel exhaust particles to attenuate adverse effects of diesel exhaust on lung function and on allergic responses.

2. Hypotheses:

Hypothesis 1: Allergen-specific immune response (specific IgG4, etc; relevant responses in DNA methylation and proteomics) in allergen-challenged airways in sensitized individuals is increased by diesel exhaust "synergy".

Hypothesis 2: Synergistic responses will be greater in asthmatics than in non-asthmatics.

Hypotheses 3: Synergy is attributable to the particulate fraction of DE (i.e. is normalized by particle depletion).

3. Justification:

Diesel exhaust consists of both gaseous and particulate air pollutants. In recent studies, cardiovascular effects seem attenuated when the particulate portion is removed. We would like to know if that is true for respiratory and immunological endpoints. Understanding these changes may help us prevent health problems associated with air pollution in the future.

4. Research Method:

Blinded crossover experiment between four conditions (DE and allergen, PDDE and allergen, FA and allergen, FA and saline), randomized and counter-balanced to order. Each condition will be separated by a 4-week washout period.

An inhaled allergen or saline challenge is delivered after each exposure (DE, PDDE, or FA). 24 h post challenge, airway reactivity will be assessed with a methacholine challenge. 48 h post challenge, bronchoalveolar lavage (BAL), airway brushes and tissue biopsies will be obtained for analysis of immune activation. Nasal lavage samples will also be collected to examine responses in the upper airways and blood and urine will be studied to examine systemic responses. Spirometry and methacholine challenge will be used to assess effects on airway function. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02017431
Study type Interventional
Source University of British Columbia
Contact
Status Completed
Phase N/A
Start date January 2014
Completion date April 2017

See also
  Status Clinical Trial Phase
Completed NCT01612936 - T Cell Effector and Regulatory Mechanisms in Asthma Phase 1
Completed NCT00779116 - Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) Phase 4
Recruiting NCT06002685 - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention N/A
Completed NCT04644783 - Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES) N/A
Recruiting NCT05635266 - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed NCT01792232 - Effects of Co-Exposure to Air Pollution and Allergen N/A
Completed NCT01454505 - Safety and Efficacy of AL-53817 Nasal Spray Solution Phase 1
Completed NCT00800332 - Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy Phase 2
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Recruiting NCT05119868 - Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring N/A
Completed NCT00801502 - Salmon in Pregnancy Study N/A
Completed NCT00453583 - Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine N/A
Unknown status NCT00892684 - Does Omega-3 Fatty Acid Supplementation in Pregnancy and During Lactation Protect the Child From Allergic Disease? N/A
Completed NCT00700726 - Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic Asthma N/A
Recruiting NCT00350376 - Impact of Asthma Treatments on Daily Activities N/A
Completed NCT00881634 - To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions Phase 1
Completed NCT00881127 - To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions Phase 1
Completed NCT03106493 - Upstate New York Infant Development Screening Program
Completed NCT01711593 - Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma Phase 1
Completed NCT01529437 - Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies Phase 1